What's behind Depo-Provera claims?
Depo-Provera is a widely used injectable contraceptive. Recent research has found an association between prolonged use of the drug and an increased risk of meningioma — a typically slow-growing but potentially serious brain tumor that can require surgery.
Claims allege that the manufacturer knew or should have known about this risk and failed to adequately warn patients and prescribing physicians. Litigation in this case type is still emerging.
Case criteria we screen for
Cases we source and qualify in this case type generally involve:
- A documented history of prolonged Depo-Provera (or generic equivalent) use
- A diagnosis of meningioma
- Medical records supporting both the prescription history and the diagnosis
Law firm partners can share additional intake criteria at onboarding to keep referrals aligned with their practice.
How the process works
For our partners, it's straightforward:
- Law firms — tell us your capacity and any specific intake criteria; we route qualified, vetted cases in this case type to you.
- Ongoing — reporting and a dedicated contact keep volume and quality aligned.
This is an emerging case type with new litigation developments, which is part of why timely intake matters here in particular.
Frequently asked questions
Is there a filing deadline for this case type?+
Yes. Statutes of limitations vary by state, which is part of why timely, accurate intake matters.
How are cases priced or valued?+
That depends on the partnership terms agreed at onboarding — reach out and we'll walk through current terms for this case type.
What compliance standards apply to this case type?+
We maintain vetted qualification criteria and intake standards for this case type to keep everything compliant with advertising and TCPA requirements.